دورية أكاديمية
Murine Models of Gastric Corpus Preneoplasia.
العنوان: | Murine Models of Gastric Corpus Preneoplasia. |
---|---|
المؤلفون: | Petersen CP; Nashville VA Medical Center, Nashville, Tennessee; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee; Epithelial Biology Center, Vanderbilt University, Nashville, Tennessee., Mills JC; Division of Gastroenterology, Department of Medicine, Pathology and Immunology, Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri., Goldenring JR; Nashville VA Medical Center, Nashville, Tennessee; Section of Surgical Sciences, Vanderbilt University, Nashville, Tennessee; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee; Epithelial Biology Center, Vanderbilt University, Nashville, Tennessee. |
المصدر: | Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2016 Nov 16; Vol. 3 (1), pp. 11-26. Date of Electronic Publication: 2016 Nov 16 (Print Publication: 2017). |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: American Gastroenterological Association Country of Publication: United States NLM ID: 101648302 Publication Model: eCollection Cited Medium: Print ISSN: 2352-345X (Print) Linking ISSN: 2352345X NLM ISO Abbreviation: Cell Mol Gastroenterol Hepatol Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Philadelphia, PA : American Gastroenterological Association, [2015]- |
مستخلص: | Intestinal-type gastric adenocarcinoma evolves in a field of pre-existing metaplasia. Over the past 20 years, a number of murine models have been developed to address aspects of the physiology and pathophysiology of metaplasia induction. Although none of these models has achieved true recapitulation of the induction of adenocarcinoma, they have led to important insights into the factors that influence the induction and progression of metaplasia. Here, we review the pathologic definitions relevant to alterations in gastric corpus lineages and classification of metaplasia by specific lineage markers. In addition, we review present murine models of the induction and progression of spasmolytic polypeptide (TFF2)-expressing metaplasia, the predominant metaplastic lineage observed in murine models. These models provide a basis for the development of a broader understanding of the physiological and pathophysiological roles of metaplasia in the stomach. |
References: | Lab Invest. 1999 Jun;79(6):639-46. (PMID: 10378506) J Immunol. 1999 Aug 1;163(3):1490-7. (PMID: 10415051) Gastroenterology. 2000 Jan;118(1):36-47. (PMID: 10611152) Gastroenterology. 2000 Jun;118(6):1080-93. (PMID: 10833483) J Clin Invest. 2000 Dec;106(12):1447-55. (PMID: 11120752) Annu Rev Physiol. 2001;63:119-39. (PMID: 11181951) Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G359-66. (PMID: 11804858) Gastroenterology. 2002 Mar;122(3):689-96. (PMID: 11875002) Dig Dis Sci. 2002 Mar;47(3):573-8. (PMID: 11911345) Biochem Biophys Res Commun. 2002 Jun 7;294(2):470-9. (PMID: 12051735) Dig Dis Sci. 2003 Mar;48(3):431-41. (PMID: 12757153) Gastroenterology. 2003 Jun;124(7):1879-90. (PMID: 12806621) Yale J Biol Med. 1992 Nov-Dec;65(6):793-804; discussion 827-9. (PMID: 1341079) Acta Pathol Microbiol Scand. 1965;64:31-49. (PMID: 14320675) Gastroenterology. 1992 Dec;103(6):1950-63. (PMID: 1451986) Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4471-6. (PMID: 15070742) Gastroenterology. 2004 Aug;127(2):582-94. (PMID: 15300590) Shock. 2004 Nov;22(5):460-6. (PMID: 15489639) Science. 2004 Nov 26;306(5701):1568-71. (PMID: 15567866) Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G362-75. (PMID: 15647607) Oncogene. 2005 Mar 31;24(14):2354-66. (PMID: 15735748) Cancer Res. 2005 Apr 1;65(7):2746-54. (PMID: 15805274) Gastroenterology. 2005 Apr;128(4):935-45. (PMID: 15825076) Gastroenterology. 2005 May;128(5):1292-305. (PMID: 15887112) Cancer Res. 2005 Oct 15;65(20):9147-51. (PMID: 16230370) Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G793-804. (PMID: 16306133) Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G970-9. (PMID: 16399875) Dig Dis Sci. 2006 Mar;51(3):431-9. (PMID: 16614949) Mol Cell Biol. 2006 Jun;26(12):4474-88. (PMID: 16738314) Hum Pathol. 2006 Sep;37(9):1162-8. (PMID: 16938521) Gastroenterology. 2006 Oct;131(4):1086-95. (PMID: 17030179) Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G999-1004. (PMID: 17090722) J Clin Invest. 2007 Jan;117(1):70-80. (PMID: 17200708) J Gastroenterol. 2007 Jan;42 Suppl 17:7-9. (PMID: 17238018) Gastroenterology. 2007 May;132(5):1804-19. (PMID: 17484876) J Pathol. 2007 Oct;213(2):161-9. (PMID: 17763396) Lab Invest. 2007 Dec;87(12):1265-76. (PMID: 18004396) Cancer Res. 2008 Jan 15;68(2):379-87. (PMID: 18199531) Gastroenterology. 2008 Feb;134(2):511-22. (PMID: 18242217) J Clin Invest. 2008 Jul;118(7):2459-70. (PMID: 18535670) Cancer Cell. 2008 Nov 4;14(5):408-19. (PMID: 18977329) Histol Histopathol. 2009 Jan;24(1):31-40. (PMID: 19012242) Dev Biol. 2009 Jan 1;325(1):211-24. (PMID: 19013146) Gastroenterology. 2009 Mar;136(3):967-77. (PMID: 19121317) Gastroenterology. 2009 Apr;136(4):1288-96. (PMID: 19230855) Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1211-20. (PMID: 19359424) Dig Dis Sci. 2009 Aug;54(8):1625-35. (PMID: 19507031) Gastric Cancer. 2009;12(4):189-97. (PMID: 20047123) Gastroenterology. 2010 Jun;138(7):2207-10, 2210.e1. (PMID: 20450866) Am J Pathol. 2010 Sep;177(3):1514-33. (PMID: 20709804) Am J Physiol Gastrointest Liver Physiol. 2010 Dec;299(6):G1241-51. (PMID: 20813912) Gastroenterology. 2010 Dec;139(6):2050-2060.e2. (PMID: 20826155) Gastroenterology. 2010 Dec;139(6):2028-2037.e9. (PMID: 20854822) Gastroenterology. 2011 Feb;140(2):596-607.e7. (PMID: 21070778) Gastroenterology. 2011 Mar;140(3):879-91. (PMID: 21111741) Gastroenterology. 2011 May;140(5):1536-46.e8. (PMID: 21277301) PLoS One. 2011 Feb 02;6(2):e16786. (PMID: 21311774) J Korean Med Sci. 2011 May;26(5):647-53. (PMID: 21532856) Gastroenterology. 2011 Aug;141(2):476-85, 485.e1-11. (PMID: 21684283) Exp Cell Res. 2011 Nov 15;317(19):2759-64. (PMID: 21907708) Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G21-33. (PMID: 21995960) Gastroenterology. 2012 Jan;142(1):21-24.e7. (PMID: 22001866) Gastroenterology. 2012 Feb;142(2):281-91. (PMID: 22062361) Gastroenterology. 2012 Feb;142(2):292-304. (PMID: 22079592) Gastroenterology. 1990 Nov;99(5):1315-23. (PMID: 2210240) Gut. 2012 Oct;61(10):1398-409. (PMID: 22180059) J Dig Dis. 2012 Jan;13(1):2-9. (PMID: 22188910) Gut. 2012 May;61(5):673-84. (PMID: 22315472) Gut. 2013 Feb;62(2):192-200. (PMID: 22362916) Lab Invest. 2012 Jun;92(6):883-95. (PMID: 22411066) Lab Invest. 2012 Jul;92(7):1045-57. (PMID: 22525425) Gut. 2013 Sep;62(9):1270-9. (PMID: 22773549) Am J Pathol. 2012 Nov;181(5):1560-72. (PMID: 22944598) Nature. 1990 Jan 4;343(6253):82-5. (PMID: 2296294) Am J Pathol. 2012 Dec;181(6):2114-25. (PMID: 23036899) Int J Cancer. 2013 Mar 15;132(6):1260-71. (PMID: 23180629) Cancer Res. 2013 Apr 1;73(7):2117-26. (PMID: 23378345) Gastroenterology. 2013 Apr;144(4):705-17. (PMID: 23415801) J Biol Chem. 2013 May 31;288(22):16085-97. (PMID: 23589310) Physiol Genomics. 2013 Aug 1;45(15):667-83. (PMID: 23715263) Mediators Inflamm. 2013;2013:608187. (PMID: 23766561) Cancer Sci. 2013 Oct;104(10):1323-9. (PMID: 23848514) Med Oncol. 2013 Dec;30(4):632. (PMID: 24105022) Acta Physiol Scand. 1985 Sep;125(1):135-43. (PMID: 2413720) Gastroenterology. 2014 Jun;146(7):1727-38.e8. (PMID: 24534633) Gastroenterology. 2014 Aug;147(2):396-406.e7. (PMID: 24751878) J Gastric Cancer. 2014 Jun;14(2):67-86. (PMID: 25061535) Nature. 2014 Sep 11;513(7517):202-9. (PMID: 25079317) Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G777-92. (PMID: 25190476) Cancer Prev Res (Phila). 2015 Jun;8(6):492-501. (PMID: 25813526) Sci Signal. 2015 Jul 14;8(385):re8. (PMID: 26175494) Physiol Rep. 2015 Aug;3(8):null. (PMID: 26290525) Curr Protoc Pharmacol. 2015 Jun 01;69:14.34.1-35. (PMID: 26344212) Cancer Cell. 2015 Dec 14;28(6):800-814. (PMID: 26585400) Gastroenterology. 2016 Apr;150(4):918-30.e13. (PMID: 26677984) Cancer Sci. 2016 Apr;107(4):391-7. (PMID: 27079437) J Pathol. 2016 Aug;239(4):399-410. (PMID: 27125972) Methods Mol Biol. 2016;1422:329-39. (PMID: 27246044) Cell Mol Gastroenterol Hepatol. 2016 Sep;2(5):546-559. (PMID: 27642625) Gastroenterology. 2017 Jan;152(1):218-231.e14. (PMID: 27670082) Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):625-647. (PMID: 27766298) Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):605-624. (PMID: 27990460) Cell Mol Gastroenterol Hepatol. 2015 Jan 03;1(2):203-221.e3. (PMID: 28210674) Gut. 1986 Nov;27(11):1338-46. (PMID: 2878860) Cancer Res. 1988 Jul 1;48(13):3554-60. (PMID: 3288329) Gastroenterology. 1972 Dec;63(6):937-42. (PMID: 4565259) Virchows Arch B Cell Pathol Incl Mol Pathol. 1982;39(1):31-40. (PMID: 6123179) Am J Physiol. 1980 Apr;238(4):G312-20. (PMID: 6246807) Gut. 1978 Aug;19(8):689-98. (PMID: 680601) J Exp Med. 1995 Feb 1;181(2):713-21. (PMID: 7836924) Development. 1995 Jan;121(1):149-61. (PMID: 7867496) Anat Rec. 1993 Jun;236(2):259-79. (PMID: 8338232) Anat Rec. 1993 Jun;236(2):280-96. (PMID: 8338233) Gastroenterology. 1996 Jan;110(1):155-66. (PMID: 8536852) Dig Dis Sci. 1996 Apr;41(4):773-84. (PMID: 8674399) Pathol Res Pract. 1996 Feb;192(2):101-6. (PMID: 8692709) Gastroenterology. 1998 Apr;114(4):675-89. (PMID: 9516388) Cell. 1998 Sep 18;94(6):703-14. (PMID: 9753318) |
معلومات مُعتمدة: | R01 DK094989 United States DK NIDDK NIH HHS; R01 DK071590 United States DK NIDDK NIH HHS; R01 DK101332 United States DK NIDDK NIH HHS; F31 DK104600 United States DK NIDDK NIH HHS; I01 BX000930 United States BX BLRD VA; P30 DK052574 United States DK NIDDK NIH HHS; R01 DK105129 United States DK NIDDK NIH HHS |
فهرسة مساهمة: | Keywords: ATPase, adenosine triphosphatase; BMP, bone morphogenic protein; Chief Cell; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; Gastric Cancer; Hip1r, Huntington interacting protein 1 related; Hyperplasia; IFN, interferon; Intestinal Metaplasia; MUC, mucin; SDF1, stromal-derived factor 1; SPEM; SPEM, spasmolytic polypeptide–expressing metaplasia; TFF, trefoil factor; TFF2; TGF, transforming growth factor; Tg, transgene; Th, T-helper |
تواريخ الأحداث: | Date Created: 20170209 Latest Revision: 20220318 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC5247421 |
DOI: | 10.1016/j.jcmgh.2016.11.001 |
PMID: | 28174755 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!